Pharmacokinetics of antituberculosis drugs in Thai population

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210323004

Enrollment

100

Registered

2021-03-23

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thai adults with active TB pharmacokinetics adult TB pharmacogenetics first-line antituberculosis drugs second-line antituberculosis drugs tuberculosis

Interventions

Adult active TB patients

Treatment

TB patients

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adults, males or females who are 18 - 65 years old. 2. Diagnosed with active TB 3. Voluntarily sign and date an informed consent

Exclusion criteria

Exclusion criteria: 1. Diagnosed with acute hepatitis or cirrhosis 2. Pregnant or breastfeeding

Design outcomes

Primary

Measure	Time frame
Tmax, Cmax, AUC 0, 1, 2, 4, 6, 8, 12 hrs liquid chromatography mass spectrometry	—

Secondary

Measure	Time frame
genotype variants 1 hr after dosing MassARRAY	—

Countries

Thailand

Contacts

Public ContactPajaree Chariyavilaskul

Department of Pharmacology, Faculty of medicine, Chulalongkorn University

buaying846@gmail.com022564481

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026